CROs/Service Providers

Quotient Clinical acquires SeaView Research

Wednesday, February 8, 2017

Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the U.S. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.

[Read More]

Chiltern expands in Bangalore, India

Wednesday, February 1, 2017

Chiltern, a global CRO, has announced the opening of its new process and technology center in Bangalore, India. The new office is a direct result of the company’s continued success and fulfills a need to further enhance its global data capabilities.

[Read More]

Porton USA to acquire J-STAR Research

Monday, January 30, 2017

Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, has announced that Porton USA, a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of J-STAR Research, a contract chemistry organization based in South Plainfield, New Jersey, under which PTC will acquire J-STAR from its shareholders for no more than $26 million in cash.

[Read More]

Accelsiors expands global footprint

Tuesday, January 24, 2017

Accelsiors has announced the opening of a new office in Gurgaon, India. This investment will provide our biotechnology, pharmaceutical and medical device customers with greater access to patient populations in an increasingly well-regulated environment.

[Read More]